Two online pharmacies under fire from the FDA and DEA
It’s imperative for Florida business owners to use caution when operating online. Recently, websites selling prescription medications online have come under fire from the DEA and FDA.
How two websites came under fire
The FDA has categorized Adderall as a Schedule II stimulant, meaning that someone needs a prescription to obtain and use this medication. However, both the FDA and DEA recently learned about two websites selling products marketed as Adderall for sale without a prescription requirement.
The FDA’s and DEA’s warning letters
Soon, joint warning letters came from the DEA and FDA directed at the website owners that were selling Adderall online. The FDA’s current commissioner gave a statement on this situation stating that these websites contribute to “potential abuse, misuse and overdose.” Both agencies recommend that anyone in possession of these counterfeit medications should dispose of them immediately.
The people involved with the operation of this website could face drug offenses if the website remains in operation. According to the FDA, this website’s owners are also in violation of the Ryan Haight Online Pharmacy Act. Created in 2008, the Ryan Haight Online Pharmacy Act helps prevent the online sale of prescription medications.
This act also lists information about how a company can sell medications online legally. However, this business would need to register itself with the DEA before it could officially operate. The owners of the website in question that was selling Adderall did not register with the DEA.
If you’re potentially facing drug charges from selling medications online, you could face charges involving the intent to sell, manufacture or deliver drugs. Fortunately, first-time offenders may have a chance to obtain a reduced sentence if found guilty.